arrow
M

Mohd H. Abdul-Aziz

the frazer institute
H指数:26
被引数:4,864

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vancomycin optimised dosing regimens for critically ill patients receiving renal replacement therapy

万古霉素优化给药方案用于接受肾脏替代治疗的危重患者

2026-08-040
OA
Population pharmacokinetics of polymyxin B in critically ill patients with multidrug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa infections

多药耐药鲍曼不动杆菌和铜绿假单胞菌感染危重患者中多黏菌素B的群体药代动力学

2026-04-210
OAAI
Population pharmacokinetics of total and free ceftriaxone in critically ill and non-critically ill hospitalised adult patients

曲松钠总浓度和游离浓度在危重和非危重住院成年患者中的群体药代动力学

2026-04-210
OAAI
How to perform pharmacokinetic research of antimicrobial drugs in critically ill patients undergoing continuous renal replacement therapy: a scoping review of all relevant pharmacokinetic factors

如何在接受连续性肾脏替代治疗的危重患者中进行抗菌药物药代动力学研究:一项关于所有相关药代动力学因素的范畴综述

2025-12-020
OAAI
Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment

美罗培南在第一天给药剂量优化及在无显著肾功能损害的重症患者的稳态给药

2025-10-290
OA
Impact of COVID-19 on healthcare programs in Zimbabwe: a mixed methods study

COVID-19对津巴布韦医疗项目的影响:一项混合方法研究

2025-05-130
OA
Population pharmacokinetics of caspofungin in critically ill patients receiving extracorporeal membrane oxygenation-an ASAP ECMO study

卡泊芬净在接受体外膜氧合的危重患者中的群体药代动力学-一项ASAP ECMO研究

2025-02-130
OAAI
Prolonged vs Intermittent Infusions of β-Lactam Antibioticsin Adults With Sepsis or Septic Shock A Systematic Review and Meta-Analysis

长期与间歇性输注 β-内酰胺类抗生素治疗成人脓毒症或脓毒症休克的系统评价和荟萃分析

2024-08-278
PRE